Target intelligence / Profile preview

Cyclin-A2 RxL substrate-binding groove (CCNA2 RxL groove)

Target
CCNA2 RxL groove
Molecular classification
Cyclin, Protein-protein interaction site, Hydrophobic patch
01

Overview

The Cyclin A RxL substrate-binding groove, also known as the hydrophobic patch or recruitment site, is a specialized protein-protein interaction surface located on Cyclin A2 (CCNA2). This groove is characterized by a conserved MRAIL sequence that recognizes and binds to the RxL (Arg-x-Leu) motif found in various cell cycle substrates and regulators, including E2F1, p21, and p27 (nih.gov, 1.1.1, 1.1.2). By facilitating these interactions, the groove enables the Cyclin A-CDK2 complex to phosphorylate specific targets required for DNA replication during S-phase and the subsequent transition into mitosis (wikipedia.org, 1.3.1). In many cancers, particularly those with RB1 or TP53 mutations, the G1-S checkpoint is compromised, leading to dysregulated and high E2F activity (biorxiv.org, 1.2.4). Therapeutic targeting of this groove with macrocyclic peptides or small molecules, such as CID-078, competitively inhibits substrate recruitment, paradoxically hyperactivating E2F1 and inducing mitotic catastrophe (cancer.gov, 1.2.3). This mechanism provides a synthetic lethal approach for treating E2F-driven malignancies like small-cell lung cancer while maintaining a therapeutic window relative to normal cells (nih.gov, 1.2.1).

Other names
Hydrophobic patchCyclin-binding groove (CBG)Recruitment siteCy-motif binding siteMRAIL motif
02

Mechanism of action

Competitive inhibition of RxL-motif substrate binding to Cyclin A2, leading to E2F1 hyperactivation and disruption of the Cyclin B-Myt1 interaction, which triggers the spindle assembly checkpoint and apoptotic cell death.

03

Biological functions

Cell cycle regulationSubstrate recruitmentDNA replicationDNA repairS-phase progressionG2/M transition
04

Disease associations

CancerSmall-cell lung cancer (SCLC)Breast cancerHepatocellular carcinomaPancreatic ductal adenocarcinoma
05

Safety considerations

Potential toxicity to normal dividing cellsOff-target inhibition of other cyclins (e.g., Cyclin E)Formation of neomorphic Cyclin B-CDK2 complexesTherapeutic window challenges in non-E2F-driven tissues
06

Interacting drugs

CID-078

4 more in the full profile.

07

Biomarkers

E2F activity signatureRB1 loss-of-functionTP53 loss-of-functionCyclin A2 expression levels

Beyond the preview

Go deeper on Cyclin-A2 RxL substrate-binding groove (CCNA2 RxL groove).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin-A2 RxL substrate-binding groove (CCNA2 RxL groove).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call